OPKO Health Reports Officer Changes & Compensation Arrangements
Ticker: OPK · Form: 8-K · Filed: Feb 9, 2024 · CIK: 944809
| Field | Detail |
|---|---|
| Company | Opko Health, INC. (OPK) |
| Form Type | 8-K |
| Filed Date | Feb 9, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: officer-changes, compensation, corporate-governance
TL;DR
**OPKO Health just announced executive changes and new pay deals, watch for strategic shifts.**
AI Summary
OPKO Health, Inc. filed an 8-K on February 9, 2024, reporting a 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.' This filing indicates changes in key personnel and their compensation structures, which could impact the company's strategic direction and operational efficiency. Investors should pay attention to these changes as they might signal shifts in leadership and future performance, potentially affecting stock value.
Why It Matters
Changes in executive leadership and compensation can significantly influence a company's future strategy, financial health, and investor confidence, directly impacting stock performance.
Risk Assessment
Risk Level: medium — Changes in leadership can introduce uncertainty regarding future company direction and performance, posing a moderate risk to investors.
Analyst Insight
An investor should monitor subsequent filings or company announcements for details on the specific individuals involved in the officer changes and the nature of their compensatory arrangements to assess potential impacts on company strategy and financial health.
Key Numbers
- $0.01 — Par value per share (The par value of OPKO Health's Common Stock.)
Key Players & Entities
- OPKO HEALTH, INC. (company) — the registrant filing the 8-K
- February 9, 2024 (date) — date of earliest event reported
- $0.01 (dollar_amount) — par value per share of Common Stock
- NASDAQ Global (company) — exchange where Common Stock is registered
FAQ
What is the specific item number reported in this 8-K filing?
The specific item information reported is 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers'.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is February 9, 2024.
What is the trading symbol for OPKO Health, Inc. common stock?
The trading symbol for OPKO Health, Inc. common stock is OPK.
On which exchange is OPKO Health, Inc.'s common stock registered?
OPKO Health, Inc.'s common stock is registered on the NASDAQ Global exchange.
What is the business address of OPKO Health, Inc. as stated in the filing?
The business address of OPKO Health, Inc. is 4400 Biscayne Blvd., Miami, Florida, 33137.
Filing Stats: 482 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-02-09 16:07:24
Key Financial Figures
- $0.01 — ch registered Common Stock , par value $0.01 per share OPK NASDAQ Global Select M
Filing Documents
- opk20240209_8k.htm (8-K) — 24KB
- 0001437749-24-003630.txt ( ) — 153KB
- opk-20240209.xsd (EX-101.SCH) — 3KB
- opk-20240209_def.xml (EX-101.DEF) — 11KB
- opk-20240209_lab.xml (EX-101.LAB) — 15KB
- opk-20240209_pre.xml (EX-101.PRE) — 11KB
- opk20240209_8k_htm.xml (XML) — 3KB
02
ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 9, 2024, Alexis Borisy, a member of the Board of Directors (the " Board ") of OPKO Health, Inc. (the " Company "), and a member of Compensation Committee of the Board, informed the Board that he does not intend to stand for reelection at the Company's 2024 Annual Meeting of Stockholders. Accordingly, Mr. Borisy's service as a member of the Board will cease at the Company's 2024 Annual Meeting of Stockholders scheduled to be held on March 28, 2024, at which time the Board will be reduced to 11 members. Mr. Borisy's decision not to stand for reelection is not a result of any disagreement with the Company.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OPKO Health, Inc. By: /s/ Steven D. Rubin Date: February 9, 2024 Name: Steven D. Rubin Title: Executive Vice President-Administration